EUR USD GBP
+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Brazil - PhaseZero Market Insight Report

  • ID: 1283555
  • Country Profile
  • July 2010
  • Region: Brazil
  • 25 Pages
  • Whythawk
1 of 3
Whythawk PhaseZero reports offer rapid, high-level comparative country insight. Our reports combine quantitative and qualitative content with striking data visualisation. To assist comprehension, chart elements - called sparklines - are integrated throughout the report to allow concise and immediate comparisons of all reported data.

Charts and data are presented relative to a benchmark of leading emerging market investment destinations. All content is comprehensively referenced with online links embedded into the report for immediate access to source documentation.

Brazil has been analysed according to the following segments:

1. Demography: Population, Health and Education
2. Economy: Market Opportunity and Investment Environment
3. Infrastructure: Telecommunications, Energy, Access and Rights
4. State: Governance, Law and Stability
5. Structure: Aid, Enterprise and State Expenditure
6. Healthcare: Morbidity, Mortality & Treatment

A flavour of major economic opportunities and risks highlighted in the PhaseZero Brazil report:

- Norsk Hydro has agreed to buy the aluminium assets of Vale, the Brazilian metals and mining group, in a $4.9 billion deal that will secure the Norwegian company's raw material supplies for decades. Norsk Hydro, Europe's third largest aluminium maker, expects the deal to boost its competitiveness by providing a long-term supply of high-quality, cost-efficient raw materials.

- Dutch oil company, Shell, and Brazilian company, Cosan, are to form a $12.0 billion joint venture to produce ethanol from sugar cane in Brazil. The two companies signed a memorandum of understanding for the 50:50 joint venture, under which both companies will contribute existing Brazilian assets to the new company

- Brazil's economy is likely to see around $45.0 billion in foreign direct investment in 2010 and faces a current-account deficit of $50.0 billion, according to Central Bank President Henrique Meirelles. After enacting a range of stimulus measures during the global economic crisis, the country has already started moving toward monetary tightening. In February 2010, the statutory reserve requirements for banks were raised by 2.0 percentage points in a first step toward reducing excess liquidity.

- Brazil has occasional denied patent right to foreign companies for critical HIV drugs, arguing that preventative drugs should be made easily accessible to those suffering from the illness. In 2007, Lula issued a ""compulsory license"" to override the patent of an AIDS drug made by the US pharmaceutical giant Merck. This came after a dispute in pricing led to the government allowing the manufacture of a generic version of the drug Efavirenz.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Brazil Market Insight Contents

Country Overview
Introduction to Brazil
The Bue Curve and Emerging Market Analysis
Methodology: Bue Analysis
Bue Analysis
Comparative GDP Forecast, and Exchange Rate Base Year and Value
Segment 1: Demography
Segment 2: Economy
Segment 3: Infrastructure
Segment 4: State
Segment 5: Structure
Segment 6: Healthcare
Bue Analysis Conclusions
References: Data Sources
References: Content Sources

Brazil Market Insight Figures

Key Country Rankings (Brazil), 2010
Bue Curve - Summary of Results (Brazil), 2010
Gross domestic product, current prices in US dollars (Brazil), 2010
Brazilian Real Vs. US Dollar, 2000 - 2009
Key Population and Education Indicators (Brazil), 2010
Key Health Indicators (Brazil), 2010
Key Market Opportunity Indicators (Brazil), 2010
Key Investment Environment Indicators (Brazil), 2010
Key Telecommunications Indicators (Brazil), 2010
Key Energy Indicators (Brazil), 2010
Key Governance and Legal Indicators (Brazil), 2010
Key Stability Indicators (Brazil), 2010
Key State Ease of Business Indicators (Brazil), 2010
Key Aid and Enterprise Indicators (Brazil), 2010
Key Mortality and Morbidity Indicators (Brazil), 2010
Key Treatment Indicators (Brazil), 2010
Final Table of Bue Scores (Brazil), 2010
Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown
Adroll
adroll